Man using laptop
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Xero Ltd (ASX:XRO) said its earnings before interest, tax, depreciation and amortisation (EBITDA) for the half of the 2025 fiscal year had jumped 51% (to $311.7 million) compared to the prior corresponding period.

The Wellinton-based company – which provides accounting software – also said earnings growth had been supported by a 25% rise in operating revenue (to $996 million), and an operating expense to revenue ratio of 71.2% for the period.

Xero’s free cash flow was also higher, rising to $208.7 million, alongside a free cash flow margin of 21.0% – improving from 13.3% in the prior period.

These figures meant the company maintained its greater than Rule of 40 outcome of 43.9%.

CEO Sukhinder Singh Cassidy said the results reflected Xero’s success in achieving strategic goals.

“We have delivered a solid performance across the board this half including continued strong revenue growth, and a greater than Rule of 40 outcome for the second period running,” he said.

“We’re executing our strategy with focus and purpose, through disciplined investment aligned to our strategic priorities.

“This has supported an improvement in product velocity for customers in line with
our Win the 3×3 strategic priority to build winning solutions for the three most critical small business jobs in our three largest markets.”

Xero has been trading at $161.55.

Join the discussion: See what HotCopper users are saying about Xero and be part of the conversations that move the markets.

XRO by the numbers
More From The Market Online
HotCopper Daily Market Trends Graphic

Monday’s HotCopper Trends: Spartan and Ramelius merger, Arizona capital raise | March 17, 2025

The ASX has been up 0.62% at 7,837 points, following Wall Street’s Friday lead.
Conveyor belt

Image Res eyes 10cps as first heavy concentrate shipped to port

Image Resources jumped 4% in Monday trades after shipping its first heavy mineral concentrate to Geraldton…
Machu Pichu in Peru

Altair confirms 4th porphyry at Venatica West, with high-grade Cu over 700m

Altair Minerals Ltd has identified a fourth porphyry system at its Venatica West project in Peru,…
Cancer concept

Radiopharm has seen breast cancer tumour reductions in first-phase trials

Radiopharm reports its drug 177Lu-RAD202 with a similar imaging agent has seen some patients with breast…